Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

(2020) Fei Zhou et al.   LANCET

The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment

(2020) Felipe Ornell et al.   PSYCHIATRY RESEARCH

Substance misuse during COVID-19: protecting people who use drugs

(2020) R. Armitage et al.   PUBLIC HEALTH

“Pandemic fear” and COVID-19: mental health burden and strategies

(2020) Felipe Ornell et al.   REVISTA BRASILEIRA DE PSIQUIATRIA

Addressing the Syndemic of HIV, Hepatitis C, Overdose, and COVID-19 Among People Who Use Drugs: The Potential Roles for Decriminalization and Safe Supply

(2020) Matthew Bonn et al.   Journal of Studies on Alcohol and Drugs

Alcohol, Cannabis, and Opioid Use Disorders, and Disease Burden in an Integrated Health Care System

(2017) Amber L. Bahorik et al.   Journal of Addiction Medicine

Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria

(2016) Rebecca McDonald et al.   ADDICTION

Hydromorphone Compared With Diacetylmorphine for Long-term Opioid Dependence

(2016) Eugenia Oviedo-Joekes et al.   JAMA Psychiatry

The Association Between Social Isolation andDSM-IVMood, Anxiety, and Substance Use Disorders

(2011) Kee-Lee Chou et al.   JOURNAL OF CLINICAL PSYCHIATRY

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

(2009) N. CRAINE et al.   EPIDEMIOLOGY AND INFECTION

Diacetylmorphine versus Methadone for the Treatment of Opioid Addiction

(2009) Eugenia Oviedo-Joekes et al.   NEW ENGLAND JOURNAL OF MEDICINE

Enhanced Negative Emotion and Alcohol Craving and Altered Physiological Responses Following Stress and Cue Exposure in Alcohol Dependent Individuals

(2008) Rajita Sinha et al.   NEUROPSYCHOPHARMACOLOGY